Summary | Promoter substitution for immunoglobin therapy

Crowdsourcing scientists around the world with orphan and dormant intellectual property (IP).

Join Us Sign In

This is the pilot version of Therapoid. Register or Sign in as a pilot user to collaborate.

Provided by: Oklahoma Medical Research Foundation (OMRF)
Tags: Bright immunoglobin Transcription factors

Short Description:

This technology pertains to immunoglobin (Ig) promoters, in particular murine Ig promoters, to function differentially.